Drug Profile
Anakinra biosimilar - Sunshine Guojian Pharmaceutical
Alternative Names: Interleukin-1 receptor antagonist - Sunshine Guojian PharmaceuticalLatest Information Update: 23 Dec 2021
Price :
$50
*
At a glance
- Originator Shanghai CP Guojian Pharmaceutical
- Class Anti-infectives; Anti-inflammatories; Antibacterials; Antigouts; Antineoplastics; Antirheumatics; Recombinant proteins
- Mechanism of Action Interleukin 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 31 Dec 2011 Discontinued - Phase-III for Rheumatoid arthritis in China (SC)
- 01 Jan 2008 Phase-III clinical trials in Rheumatoid arthritis in China (SC)